Invesco’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $76.8M | Buy |
941,581
+76,130
| +9% | +$5.5M | 0.01% | 976 |
|
|
2026
Q1 | $59M | Buy |
865,451
+431,166
| +99% | +$30.5M | 0.01% | 1016 |
|
|
2025
Q4 | $33M | Buy |
434,285
+121,228
| +39% | +$8.81M | ﹤0.01% | 1234 |
|
|
2025
Q3 | $19.2M | Buy |
313,057
+9,823
| +3% | +$512K | ﹤0.01% | 1476 |
|
|
2025
Q2 | $14.8M | Sell |
303,234
-7,095
| -2% | -$337K | ﹤0.01% | 1570 |
|
|
2025
Q1 | $15.8M | Buy |
310,329
+198,938
| +179% | +$9.93M | ﹤0.01% | 1546 |
|
|
2024
Q4 | $5.03M | Buy |
111,391
+57,582
| +107% | +$2.46M | ﹤0.01% | 2246 |
|
|
2024
Q3 | $2M | Sell |
53,809
-229,001
| -81% | -$7.67M | ﹤0.01% | 2600 |
|
|
2024
Q2 | $8.65M | Sell |
282,810
-21,820
| -7% | -$707K | ﹤0.01% | 1883 |
|
|
2024
Q1 | $8.86M | Sell |
304,630
-8,547
| -3% | -$239K | ﹤0.01% | 1884 |
|
|
2023
Q4 | $8.63M | Buy |
313,177
+104,451
| +50% | +$2.39M | ﹤0.01% | 1913 |
|
|
2023
Q3 | $4.68M | Buy |
208,726
+44,529
| +27% | +$1.66M | ﹤0.01% | 2241 |
|
|
2023
Q2 | $6.68M | Sell |
164,197
-84,877
| -34% | -$4.15M | ﹤0.01% | 2077 |
|
|
2023
Q1 | $12.1M | Buy |
249,074
+28,253
| +13% | +$1.29M | ﹤0.01% | 1650 |
|
|
2022
Q4 | $8.43M | Buy |
220,821
+120,150
| +119% | +$4.99M | ﹤0.01% | 1961 |
|
|
2022
Q3 | $5.05M | Sell |
100,671
-136,448
| -58% | -$6.69M | ﹤0.01% | 2226 |
|
|
2022
Q2 | $9.5M | Buy |
237,119
+190,370
| +407% | +$6.68M | ﹤0.01% | 1893 |
|
|
2022
Q1 | $1.75M | Buy |
46,749
+4,000
| +9% | +$154K | ﹤0.01% | 2837 |
|
|
2021
Q4 | $1.7M | Sell |
42,749
-2,221
| -5% | -$85K | ﹤0.01% | 2856 |
|
|
2021
Q3 | $1.67M | Buy |
44,970
+5,347
| +13% | +$220K | ﹤0.01% | 2900 |
|
|
2021
Q2 | $1.68M | Buy |
39,623
+11,041
| +39% | +$473K | ﹤0.01% | 2920 |
|
|
2021
Q1 | $1.35M | Buy |
28,582
+8,756
| +44% | +$520K | ﹤0.01% | 2932 |
|
|
2020
Q4 | $1.21M | Buy |
19,826
+8,324
| +72% | +$491K | ﹤0.01% | 2866 |
|
|
2020
Q3 | $537K | Sell |
11,502
-52
| -0.5% | -$2.56K | ﹤0.01% | 3098 |
|
|
2020
Q2 | $586K | Sell |
11,554
-120,407
| -91% | -$5.92M | ﹤0.01% | 3055 |
|
|
2020
Q1 | $5.89M | Buy |
131,961
+125,968
| +2,102% | +$6.34M | ﹤0.01% | 1788 |
|
|
2019
Q4 | $288K | Sell |
5,993
-367
| -6% | -$15.6K | ﹤0.01% | 3434 |
|
|
2019
Q3 | $215K | Sell |
6,360
-180
| -3% | -$7.83K | ﹤0.01% | 3531 |
|
|
2019
Q2 | $294K | Sell |
6,540
-245,539
| -97% | -$9.7M | ﹤0.01% | 3510 |
|
|
2019
Q1 | $9.49M | Buy |
252,079
+33,393
| +15% | +$1.12M | ﹤0.01% | 1604 |
|
|
2018
Q4 | $7.5M | Sell |
218,686
-2,646
| -1% | -$95.1K | ﹤0.01% | 1693 |
|
|
2018
Q3 | $10.4M | Sell |
221,332
-228,252
| -51% | -$9.44M | ﹤0.01% | 1673 |
|
|
2018
Q2 | $15.2M | Buy |
+449,584
| New | +$14M | 0.01% | 1399 |
|
|
2018
Q1 | – | Sell |
-157,017
| Closed | -$2.62M | – | 3762 |
|
|
2017
Q4 | $2.62M | Sell |
157,017
-97,441
| -38% | -$1.65M | ﹤0.01% | 2396 |
|
|
2017
Q3 | $5.09M | Buy |
254,458
+236,880
| +1,348% | +$4.64M | ﹤0.01% | 1964 |
|
|
2017
Q2 | $322K | Sell |
17,578
-220
| -1% | -$2.96K | ﹤0.01% | 3465 |
|
|
2017
Q1 | $175K | Sell |
17,798
-70,523
| -80% | -$854K | ﹤0.01% | 3623 |
|
|
2016
Q4 | $964K | Buy |
+88,321
| New | +$927K | ﹤0.01% | 3007 |
|
|
2015
Q4 | – | Sell |
-56,527
| Closed | -$1.51M | – | 3763 |
|
|
2015
Q3 | $1.51M | Buy |
56,527
+56,422
| +53,735% | +$2.41M | ﹤0.01% | 2677 |
|
|
2015
Q2 | $5K | Sell |
105
-93,011
| -100% | -$5.43M | ﹤0.01% | 4210 |
|
|
2015
Q1 | $5.67M | Sell |
93,116
-7,007
| -7% | -$428K | ﹤0.01% | 1886 |
|
|
2014
Q4 | $5.18M | Sell |
100,123
-13,123
| -12% | -$578K | ﹤0.01% | 1885 |
|
|
2014
Q3 | $4.98M | Buy |
113,246
+33,663
| +42% | +$1.05M | ﹤0.01% | 1931 |
|
|
2014
Q2 | $2.08M | Buy |
79,583
+2,021
| +3% | +$43.3K | ﹤0.01% | 2550 |
|
|
2014
Q1 | $2.03M | Sell |
77,562
-251
| -0.3% | -$6.75K | ﹤0.01% | 2576 |
|
|
2013
Q4 | $1.32M | Buy |
77,813
+26,074
| +50% | +$458K | ﹤0.01% | 2935 |
|
|
2013
Q3 | $1.11M | Buy |
+51,739
| New | +$899K | ﹤0.01% | 2954 |
|
Other funds holding PTCT
RI
JT
Invesco's PTCT Position: Q2 2026 in Review
Invesco increased its PTC Therapeutics (PTCT) stake by 8.8% in Q2 2026, buying an estimated $5.5M and bringing the position to 941,581 shares worth $76.8M. The position accounts for 0.01% of the portfolio, ranked #976.
Invesco first reported a position in PTCT in Q3 2013 and has held it in 47 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Invesco held 941,581 shares of PTC Therapeutics worth $76.8M as of Q2 2026.
- Invesco bought 76,130 PTC Therapeutics shares in Q2 2026, an estimated $5.5M.
- PTC Therapeutics made up 0.01% of Invesco's portfolio in Q2 2026, its #976 holding.
- Invesco first reported a position in PTC Therapeutics in Q3 2013 and has held it in 47 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.